Clinical Trial Update: Bioequivalence Study of Budesonide/Formoterol Easyhaler and Symbicort Turbohaler in Asthmatics [Phase 1, Phase 2]

View source ↗

Summary

A bioequivalence study comparing Budesonide/Formoterol Easyhaler with Symbicort Turbohaler in asthmatics has completed Phase 1 and Phase 2 assessments.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide/Formoterol Easyhaler (budesonide/formoterol)
• Symbicort Turbohaler (budesonide/formoterol)

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Asthma | Phase 1, Phase 2 | Status: COMPLETED